Already done for GBS, the others will be done as the money flows in from the patent sales. We need revenues to get our stock value up and hopefully catch the eye of some institutional investors. I know they don't pay much attention to stocks below $5 but if we get significant and increasing quantitative recurrent flat pack orders from the Gates Foundation and others someone may stand up and take notice, especially if we finally put out a Press Release. Those cost a pretty penny so it will have to be worthwhile news.